Senate, Health, Education, Labor and Pensions Committee ranking member Mike Enzi (R-Wyo.) this week said that a proposal by House Speaker Nancy Pelosi (D-Calif.) for a three-month extension of the Prescription Drug User Fee Act until Congress can resolve differences in House and Senate versions of a bill (HR 2900 and S 1082) to reauthorize the law, which expires on Sept. 30, is "not an option," CongressDaily reports.

According to Enzi, "the American people did not send us here to rubber stamp extensions of old programs that we all know need improvement." A Pelosi spokesperson said, "Bipartisan negotiations are taking place between the House and the Senate, and we are confident an agreement will be reached in the near future. The goal is to deliver to the president as soon as possible a bill that would guarantee drug safety and speed…